Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) was frequently used to treat patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory distress (ARDS) during the initial outbreak. Care of COVID-19 patients evolved markedly during the second part of 2020. Our object...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Matthieu, Langouet, Elise, Hajage, David, James, Sarah Aissi, Chommeloux, Juliette, Bréchot, Nicolas, Barhoum, Petra, Lefèvre, Lucie, Troger, Antoine, de Chambrun, Marc Pineton, Hékimian, Guillaume, Luyt, Charles-Edouard, Dres, Martin, Constantin, Jean-Michel, Fartoukh, Muriel, Leprince, Pascal, Lebreton, Guillaume, Combes, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502094/
https://www.ncbi.nlm.nih.gov/pubmed/34627350
http://dx.doi.org/10.1186/s13054-021-03780-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502094/
https://www.ncbi.nlm.nih.gov/pubmed/34627350
http://dx.doi.org/10.1186/s13054-021-03780-6

Ejemplares similares